Matches in Nanopublications for { ?s ?p "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP887846.RACJrzYoiz_PYtRoZritCeqckFR2-O9ocQaDE85xXy3Uw130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP887846.RACJrzYoiz_PYtRoZritCeqckFR2-O9ocQaDE85xXy3Uw130_provenance.
- NP236913.RAdOVwvHPfe-4JER0y1Cp-FhFnzz5sNyDhgrrMO2M9w0k130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236913.RAdOVwvHPfe-4JER0y1Cp-FhFnzz5sNyDhgrrMO2M9w0k130_provenance.
- NP254865.RAWQ2VVN77yg-E-YENW8ADmxJsVB6NRrVWiw3Iy2tq7_Y130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254865.RAWQ2VVN77yg-E-YENW8ADmxJsVB6NRrVWiw3Iy2tq7_Y130_provenance.
- NP254892.RAcwbURL0lLqzgbhTmEaPEt_GrkWujGsY9o1cGSUiwpK4130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP254892.RAcwbURL0lLqzgbhTmEaPEt_GrkWujGsY9o1cGSUiwpK4130_provenance.
- NP881055.RAaAlNWWEIzb58LOFdvA78yR62xgpee4WxxBumFouabOE130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881055.RAaAlNWWEIzb58LOFdvA78yR62xgpee4WxxBumFouabOE130_provenance.
- NP853810.RAX2PxuPDR1H0MP_5-873mL_68PwhqEmmGFFxqNvXF0wo130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853810.RAX2PxuPDR1H0MP_5-873mL_68PwhqEmmGFFxqNvXF0wo130_provenance.
- NP917194.RATt2tsAmhhDnHsXJVQ2dVQ-iFg0WYZJcCxwZ1kWAPwEY130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917194.RATt2tsAmhhDnHsXJVQ2dVQ-iFg0WYZJcCxwZ1kWAPwEY130_provenance.
- NP881028.RA1OKgvKYcUOsYmcD3bL6jlpRInaezRxfqIXHVLF6I6wc130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881028.RA1OKgvKYcUOsYmcD3bL6jlpRInaezRxfqIXHVLF6I6wc130_provenance.
- NP917222.RA1KeSDIVtXM54IRfJ0xwTL187IM_UDv1AeuYzdy4Y-kE130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917222.RA1KeSDIVtXM54IRfJ0xwTL187IM_UDv1AeuYzdy4Y-kE130_provenance.
- NP947965.RA2WFAbwWcFrRL8KSfDbkYuVgNrTeXuGE4PBmIMqfUwnI130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP947965.RA2WFAbwWcFrRL8KSfDbkYuVgNrTeXuGE4PBmIMqfUwnI130_provenance.
- NP1202680.RAxyfM2rlZRLy76ujKibvaDRtofqSGo8ggbcdKar1355s130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202680.RAxyfM2rlZRLy76ujKibvaDRtofqSGo8ggbcdKar1355s130_provenance.
- NP1202687.RA3jeqAbej_7LagyUygtyz_8qI_6H1qNXBdrYKNpyQEL4130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202687.RA3jeqAbej_7LagyUygtyz_8qI_6H1qNXBdrYKNpyQEL4130_provenance.
- NP1202691.RA4VR60tru7BY8U3hh0EAK9gdI4xmMVEbybXwTUFsTrEA130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202691.RA4VR60tru7BY8U3hh0EAK9gdI4xmMVEbybXwTUFsTrEA130_provenance.
- NP1202694.RA2JZcHtFJwGfkX_59uxp9yMw8lkzGy1iRo0FdbpP-aAc130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202694.RA2JZcHtFJwGfkX_59uxp9yMw8lkzGy1iRo0FdbpP-aAc130_provenance.
- NP702250.RAOaOmqC95mQC6FJtAwtirZnqd7u_TF9JkiQhI-07EdK8130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP702250.RAOaOmqC95mQC6FJtAwtirZnqd7u_TF9JkiQhI-07EdK8130_provenance.
- NP1202689.RAc8f0uwmcILIqCPdWEW0hA9R89ovtZP4abdofjNHRj20130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202689.RAc8f0uwmcILIqCPdWEW0hA9R89ovtZP4abdofjNHRj20130_provenance.
- NP1202692.RAVe3UYk0VGcFrjtWn3gkNR-9DomvusB1Zfnm_AKDdb4k130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202692.RAVe3UYk0VGcFrjtWn3gkNR-9DomvusB1Zfnm_AKDdb4k130_provenance.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP236948.RAlhrwPu3FfmYAoRoZ_mTct97wQNenO8sr3ivg_r6m9cQ130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236948.RAlhrwPu3FfmYAoRoZ_mTct97wQNenO8sr3ivg_r6m9cQ130_provenance.
- NP853758.RAHPWoTvNUdEllOoVC3Sth2tIDR3NTqNH_tUFfZdQnplw130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853758.RAHPWoTvNUdEllOoVC3Sth2tIDR3NTqNH_tUFfZdQnplw130_provenance.
- NP702412.RAsLdKBxE1pppBbZH_kgT5PfjwjQQIRx8gk3mj3-2e2oA130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP702412.RAsLdKBxE1pppBbZH_kgT5PfjwjQQIRx8gk3mj3-2e2oA130_provenance.
- NP887816.RAvuA-0YXI-Ektc91hskasI4z4qKOUVUer7Eq-QpqFpkM130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP887816.RAvuA-0YXI-Ektc91hskasI4z4qKOUVUer7Eq-QpqFpkM130_provenance.
- NP1202681.RAGLpecA8B9-m5h2n-1rx7AXln2Z9C2oVwPgNVsGxxUf4130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202681.RAGLpecA8B9-m5h2n-1rx7AXln2Z9C2oVwPgNVsGxxUf4130_provenance.
- NP1202683.RAIGjLgX75CypkFwNIfPRtnF-W56Qyr0KYm0ZPLhfv21U130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202683.RAIGjLgX75CypkFwNIfPRtnF-W56Qyr0KYm0ZPLhfv21U130_provenance.
- NP1202688.RAO9y0GmA91N7O0UKgOGwYIagiUn7-bSLRBIL6L5utgCc130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202688.RAO9y0GmA91N7O0UKgOGwYIagiUn7-bSLRBIL6L5utgCc130_provenance.
- NP1202690.RANy6TAzyn1w0zfd1o-bCcOzUmR69ea0Dyge71KIJKFD8130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202690.RANy6TAzyn1w0zfd1o-bCcOzUmR69ea0Dyge71KIJKFD8130_provenance.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP948042.RAuXqNl-ui-pL6LOSzJI3oLteIgkkyM6e2GqmSitD8H0U130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP948042.RAuXqNl-ui-pL6LOSzJI3oLteIgkkyM6e2GqmSitD8H0U130_provenance.
- NP1202677.RArNaOeS4KME9lHcDgovwleIA4HKMHd-Dm12jJ2aH-pWg130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202677.RArNaOeS4KME9lHcDgovwleIA4HKMHd-Dm12jJ2aH-pWg130_provenance.
- NP1202679.RAsKee4LzavxyIEkcHfhJCWN7-0GiqpeP_Wq2tDj8XZs0130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202679.RAsKee4LzavxyIEkcHfhJCWN7-0GiqpeP_Wq2tDj8XZs0130_provenance.
- NP1202684.RAqKgSrnCIbmCsq7M4-1BiVinH0ltXBVQDq3JiyuZZ2X0130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202684.RAqKgSrnCIbmCsq7M4-1BiVinH0ltXBVQDq3JiyuZZ2X0130_provenance.
- NP1202685.RAozz0or1gt9X5MufVA_oxwlqBqdCw-gZyz71mPZkGq-w130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202685.RAozz0or1gt9X5MufVA_oxwlqBqdCw-gZyz71mPZkGq-w130_provenance.
- NP1202686.RAofctl2EobbGT8BT0xgWqTF4ZUXIcIg_2QWXCipnSL3o130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202686.RAofctl2EobbGT8BT0xgWqTF4ZUXIcIg_2QWXCipnSL3o130_provenance.
- NP1202693.RAhhsA5LB02QpaJaRiqyYa6o-nCGiqkRpN_hDLZG7th1E130_assertion description "[Screening of a panel of 33 colon cancer cell lines identified cell lines sensitive (42%) and resistant (58%) to butyrate induction of ALP activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1202693.RAhhsA5LB02QpaJaRiqyYa6o-nCGiqkRpN_hDLZG7th1E130_provenance.